181 related articles for article (PubMed ID: 35565268)
1. Prognostic Significance of HER3 Expression in Patients with Cervical Cancer.
Chang CS; Shim JI; Byeon SJ; Lee EJ; Lee YY; Kim TJ; Lee JW; Kim BG; Choi CH
Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565268
[TBL] [Abstract][Full Text] [Related]
2. HER3 status by immunohistochemistry is correlated with poor prognosis in hormone receptor-negative breast cancer patients.
Bae SY; La Choi Y; Kim S; Kim M; Kim J; Jung SP; Choi MY; Lee SK; Kil WH; Lee JE; Nam SJ
Breast Cancer Res Treat; 2013 Jun; 139(3):741-50. PubMed ID: 23722313
[TBL] [Abstract][Full Text] [Related]
3. HER3 protein expression as a risk factor for post-operative recurrence in patients with early-stage adenocarcinoma and adenosquamous carcinoma of the cervix.
Mizuno T; Kojima Y; Yonemori K; Yoshida H; Sugiura Y; Ohtake Y; Okuma HS; Nishikawa T; Tanioka M; Sudo K; Shimomura A; Noguchi E; Kato T; Shimoi T; Uno M; Ishikawa M; Fujiwara Y; Ohe Y; Tamura K
Oncol Lett; 2020 Oct; 20(4):38. PubMed ID: 32802162
[TBL] [Abstract][Full Text] [Related]
4. Heregulin and HER3 are prognostic biomarkers in oropharyngeal squamous cell carcinoma.
Qian G; Jiang N; Wang D; Newman S; Kim S; Chen Z; Garcia G; MacBeath G; Shin DM; Khuri FR; Chen ZG; Saba NF
Cancer; 2015 Oct; 121(20):3600-11. PubMed ID: 26195293
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the prognostic significance of HER family mRNA expression in high-risk early breast cancer: a Hellenic Cooperative Oncology Group (HeCOG) validation study.
Koutras A; Kalogeras KT; Wirtz RM; Alexopoulou Z; Bobos M; Zagouri F; Veltrup E; Timotheadou E; Gogas H; Pentheroudakis G; Pisanidis N; Magkou C; Christodoulou C; Bafaloukos D; Papakostas P; Aravantinos G; Pectasides D; Kalofonos HP; Fountzilas G
J Transl Med; 2015 May; 13():171. PubMed ID: 26021752
[TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of HER3 based on protein and mRNA expression in high-grade serous ovarian carcinoma.
Unger U; Denkert C; Braicu I; Sehouli J; Dietel M; Loibl S; Darb-Esfahani S
Virchows Arch; 2017 Feb; 470(2):143-151. PubMed ID: 27913862
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical analysis of RTKs expression identified HER3 as a prognostic indicator of gastric cancer.
Ema A; Yamashita K; Ushiku H; Kojo K; Minatani N; Kikuchi M; Mieno H; Moriya H; Hosoda K; Katada N; Kikuchi S; Watanabe M
Cancer Sci; 2014 Dec; 105(12):1591-600. PubMed ID: 25455899
[TBL] [Abstract][Full Text] [Related]
8. Expression of fibroblast growth factor receptor family members is associated with prognosis in early stage cervical cancer patients.
Choi CH; Chung JY; Kim JH; Kim BG; Hewitt SM
J Transl Med; 2016 May; 14(1):124. PubMed ID: 27154171
[TBL] [Abstract][Full Text] [Related]
9. Association between the overexpression of Her3 and clinical pathology and prognosis of colorectal cancer: A meta-analysis.
Yan Q; Guo K; Feng G; Shan F; Sun L; Zhang K; Shen F; Shen M; Ruan S
Medicine (Baltimore); 2018 Sep; 97(37):e12317. PubMed ID: 30212974
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of annexin A2 and annexin A4 expression in patients with cervical cancer.
Choi CH; Chung JY; Chung EJ; Sears JD; Lee JW; Bae DS; Hewitt SM
BMC Cancer; 2016 Jul; 16():448. PubMed ID: 27402115
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of survivin and EGFR protein expression in triple-negative breast cancer (TNBC) patients.
Zhang M; Zhang X; Zhao S; Wang Y; Di W; Zhao G; Yang M; Zhang Q
Target Oncol; 2014 Dec; 9(4):349-57. PubMed ID: 24233638
[TBL] [Abstract][Full Text] [Related]
12. HER3 expression is correlated to distally located and low-grade colon cancer.
Lédel F; Stenstedt K; Hallström M; Ragnhammar P; Edler D
Acta Oncol; 2016 Jul; 55(7):875-80. PubMed ID: 26863446
[TBL] [Abstract][Full Text] [Related]
13. The prognostic significance of human epidermal growth factor receptor family protein expression in operable pancreatic cancer : HER1-4 protein expression and prognosis in pancreatic cancer.
Li Q; Zhang L; Li X; Yan H; Yang L; Li Y; Li T; Wang J; Cao B
BMC Cancer; 2016 Nov; 16(1):910. PubMed ID: 27871278
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the prognostic value of all four HER family receptors in patients with metastatic breast cancer treated with trastuzumab: A Hellenic Cooperative Oncology Group (HeCOG) study.
Koutras A; Lazaridis G; Koliou GA; Kouvatseas G; Christodoulou C; Pectasides D; Kotoula V; Batistatou A; Bobos M; Tsolaki E; Papadopoulou K; Pentheroudakis G; Papakostas P; Pervana S; Petraki K; Chrisafi S; Razis E; Psyrri A; Bafaloukos D; Kalogeras KT; Kalofonos HP; Fountzilas G
PLoS One; 2018; 13(12):e0207707. PubMed ID: 30521571
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of HER3 in patients with malignant solid tumors.
Li Q; Zhang R; Yan H; Zhao P; Wu L; Wang H; Li T; Cao B
Oncotarget; 2017 Sep; 8(40):67140-67151. PubMed ID: 28978022
[TBL] [Abstract][Full Text] [Related]
16. Nuclear HER3 expression improves the prognostic stratification of patients with HER1 positive advanced laryngeal squamous cell carcinoma.
Almadori G; Coli A; De Corso E; Mele DA; Settimi S; Di Cintio G; Brigato F; Scannone D; Carey TE; Paludetti G; Lauriola L; Ranelletti FO
J Transl Med; 2021 Sep; 19(1):408. PubMed ID: 34579737
[TBL] [Abstract][Full Text] [Related]
17. Combination of PD-L1 expression and NLR as prognostic marker in patients with surgically resected non-small cell lung cancer.
Wang X; Cao L; Li S; Wang F; Huang D; Jiang R
J Cancer; 2019; 10(26):6703-6710. PubMed ID: 31777599
[No Abstract] [Full Text] [Related]
18. Bcl-2-like Protein 11 (BIM) Expression Is Associated with Favorable Prognosis for Patients with Cervical Cancer.
Kim BW; Cho H; Ylaya K; Kitano H; Chung JY; Hewitt SM; Kim JH
Anticancer Res; 2017 Sep; 37(9):4873-4879. PubMed ID: 28870908
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of hypoxia-inducible factor-1α is a predictor of poor prognosis in cervical cancer: a clinicopathologic study and a meta-analysis.
Huang M; Chen Q; Xiao J; Yao T; Bian L; Liu C; Lin Z
Int J Gynecol Cancer; 2014 Jul; 24(6):1054-64. PubMed ID: 24978711
[TBL] [Abstract][Full Text] [Related]
20. HER3 overexpression as an independent indicator of poor prognosis for patients with curatively resected pancreatic cancer.
Hirakawa T; Nakata B; Amano R; Kimura K; Shimizu S; Ohira G; Yamada N; Ohira M; Hirakawa K
Oncology; 2011; 81(3-4):192-8. PubMed ID: 22067729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]